SEPTERNA INC (SEPN) Fundamental Analysis & Valuation
NASDAQ:SEPN • US81734D1046
Current stock price
23.09 USD
-1.74 (-7.01%)
At close:
23.09 USD
0 (0%)
After Hours:
This SEPN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. SEPN Profitability Analysis
1.1 Basic Checks
- In the past year SEPN has reported negative net income.
- SEPN had a positive operating cash flow in the past year.
1.2 Ratios
- Looking at the Return On Assets, with a value of -8.20%, SEPN is in the better half of the industry, outperforming 71.50% of the companies in the same industry.
- Looking at the Return On Equity, with a value of -12.80%, SEPN is in the better half of the industry, outperforming 73.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.2% | ||
| ROE | -12.8% | ||
| ROIC | N/A |
ROA(3y)-7.83%
ROA(5y)N/A
ROE(3y)-9.79%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for SEPN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. SEPN Health Analysis
2.1 Basic Checks
- SEPN does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for SEPN has been increased compared to 1 year ago.
- There is no outstanding debt for SEPN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 2.79 indicates that SEPN is not a great score, but indicates only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 2.79, SEPN is in the better half of the industry, outperforming 65.28% of the companies in the same industry.
- SEPN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 2.79 |
ROIC/WACCN/A
WACC9.34%
2.3 Liquidity
- SEPN has a Current Ratio of 4.73. This indicates that SEPN is financially healthy and has no problem in meeting its short term obligations.
- SEPN has a Current ratio of 4.73. This is in the better half of the industry: SEPN outperforms 63.21% of its industry peers.
- A Quick Ratio of 4.73 indicates that SEPN has no problem at all paying its short term obligations.
- SEPN has a better Quick ratio (4.73) than 64.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.73 | ||
| Quick Ratio | 4.73 |
3. SEPN Growth Analysis
3.1 Past
- SEPN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.79%, which is quite impressive.
- The Revenue has grown by 4174.51% in the past year. This is a very strong growth!
EPS 1Y (TTM)84.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.5%
Revenue 1Y (TTM)4174.51%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11276.42%
3.2 Future
- SEPN is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -18.76% yearly.
- The Revenue is expected to grow by 17.34% on average over the next years. This is quite good.
EPS Next Y-21.4%
EPS Next 2Y-32.39%
EPS Next 3Y-26.89%
EPS Next 5Y-18.76%
Revenue Next Year92.66%
Revenue Next 2Y32.48%
Revenue Next 3Y18.47%
Revenue Next 5Y17.34%
3.3 Evolution
4. SEPN Valuation Analysis
4.1 Price/Earnings Ratio
- SEPN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SEPN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Price/Free Cash Flow ratio, SEPN is valued cheaply inside the industry as 91.71% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.46 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- SEPN's earnings are expected to decrease with -26.89% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-32.39%
EPS Next 3Y-26.89%
5. SEPN Dividend Analysis
5.1 Amount
- No dividends for SEPN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
SEPN Fundamentals: All Metrics, Ratios and Statistics
23.09
-1.74 (-7.01%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-09 2026-03-09/amc
Earnings (Next)05-13 2026-05-13
Inst Owners102.02%
Inst Owner Change0%
Ins Owners3.22%
Ins Owner Change-0.06%
Market Cap1.04B
Revenue(TTM)45.95M
Net Income(TTM)-48.88M
Analysts82.86
Price Target46.41 (101%)
Short Float %4.83%
Short Ratio6.99
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-51.92%
Min EPS beat(2)-111.11%
Max EPS beat(2)7.27%
EPS beat(4)1
Avg EPS beat(4)-68.76%
Min EPS beat(4)-163.84%
Max EPS beat(4)7.27%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.69%
Min Revenue beat(2)-39.79%
Max Revenue beat(2)36.41%
Revenue beat(4)2
Avg Revenue beat(4)3.09%
Min Revenue beat(4)-98.97%
Max Revenue beat(4)114.71%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)34.39%
PT rev (3m)50.66%
EPS NQ rev (1m)-16.8%
EPS NQ rev (3m)-83.81%
EPS NY rev (1m)-32.33%
EPS NY rev (3m)-71.09%
Revenue NQ rev (1m)5.11%
Revenue NQ rev (3m)-6.34%
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)-12.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 22.57 | ||
| P/FCF | 9.46 | ||
| P/OCF | 9.41 | ||
| P/B | 2.72 | ||
| P/tB | 2.72 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.38
EYN/A
EPS(NY)-1.68
Fwd EYN/A
FCF(TTM)2.44
FCFY10.58%
OCF(TTM)2.45
OCFY10.63%
SpS1.02
BVpS8.5
TBVpS8.5
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.2% | ||
| ROE | -12.8% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | 238.67% |
ROA(3y)-7.83%
ROA(5y)N/A
ROE(3y)-9.79%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.08
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 32.29% | ||
| Cap/Sales | 1.13% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 4.73 | ||
| Quick Ratio | 4.73 | ||
| Altman-Z | 2.79 |
F-Score6
WACC9.34%
ROIC/WACCN/A
Cap/Depr(3y)173.93%
Cap/Depr(5y)N/A
Cap/Sales(3y)700.91%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.5%
EPS Next Y-21.4%
EPS Next 2Y-32.39%
EPS Next 3Y-26.89%
EPS Next 5Y-18.76%
Revenue 1Y (TTM)4174.51%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11276.42%
Revenue Next Year92.66%
Revenue Next 2Y32.48%
Revenue Next 3Y18.47%
Revenue Next 5Y17.34%
EBIT growth 1Y0.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2.39%
EBIT Next 3Y-32.02%
EBIT Next 5YN/A
FCF growth 1Y257.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y263.32%
OCF growth 3YN/A
OCF growth 5YN/A
SEPTERNA INC / SEPN Fundamental Analysis FAQ
What is the fundamental rating for SEPN stock?
ChartMill assigns a fundamental rating of 3 / 10 to SEPN.
Can you provide the valuation status for SEPTERNA INC?
ChartMill assigns a valuation rating of 2 / 10 to SEPTERNA INC (SEPN). This can be considered as Overvalued.
How profitable is SEPTERNA INC (SEPN) stock?
SEPTERNA INC (SEPN) has a profitability rating of 1 / 10.
What is the financial health of SEPTERNA INC (SEPN) stock?
The financial health rating of SEPTERNA INC (SEPN) is 7 / 10.